ArticlePharmaceuticals (Basel, Switzerland)2023

Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women.

Ting-Chun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.